Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination

Cancer vaccines that make use of tumor antigens represent a promising therapeutic strategy by stimulating immune responses against tumors to generate long-term anti-tumor immunity. However, vaccines have shown limited clinical efficacy due to inefficient delivery. In this study, we focus on vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuang, Huang, Yixian, Huang, Haozhe, Luo, Zhangyi, Zhang, Ziqian, Sun, Runzi, Wan, Zhuoya, Sun, Jingjing, Lu, Binfeng, Li, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517092/
https://www.ncbi.nlm.nih.gov/pubmed/34703645
http://dx.doi.org/10.1016/j.omtn.2021.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517092/
https://www.ncbi.nlm.nih.gov/pubmed/34703645
http://dx.doi.org/10.1016/j.omtn.2021.09.006

Ejemplares similares